Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Immunology|February 12, 2021
Myeloid Ezh2 Deficiency Limits Atherosclerosis DevelopmentAnnette E Neele, Hung-Jen Chen, Marion J J Gijbels, et al.
Blood Advances|December 23, 2021
Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killingDieke J van Rees, Maximilian Brinkhaus, Bart Klein, et al.
Cancer Immunology Research|November 7, 2019
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint InhibitionLouise W Treffers, Toine Ten Broeke, Thies Rösner, et al.
Frontiers in Immunology|November 9, 2020
SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody ProductionKatka Franke, Saravanan Y Pillai, Mark Hoogenboezem, et al.
Journal for Immunotherapy of Cancer|May 29, 2021
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatmentPaula Martinez Sanz, Dieke J van Rees, Lieke M J van Zogchel, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complexDieke J van Rees, Panagiota Bouti, Bart Klein, et al.
Frontiers in Immunology|February 15, 2019
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human NeutrophilsLouise W Treffers, Michel van Houdt, Christine W Bruggeman, et al.
Nature Medicine|March 6, 2019
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapyMeike E W Logtenberg, J H Marco Jansen, Matthijs Raaben, et al.
Cell Reports|June 28, 2018
Neutrophils Kill Antibody-Opsonized Cancer Cells by TrogoptosisHanke L Matlung, Liane Babes, Xi Wen Zhao, et al.
Journal for Immunotherapy of Cancer|April 17, 2023
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cellsMary J van Helden, Seline A Zwarthoff, Roel J Arends, et al.
Pageof 4